On March 2, 2015, Dr. Andrew Mearns Spragg, General Manager of Jellagen, a medical technology company in the United Kingdom, and Ecz. Selçuk Haydanlı visited TÜBİTAK MAM KE in order to develop a joint project within the scope of EU Horizon 2020. Within the scope of the visit, Dr. Serdar Sezer, Deputy Director of TÜBİTAK MAM KE Institute, provided information about the projects carried out/planned in the medical field and the EU Horizon 2020 calls with private sector participation. Following the presentations of the projects open to possible cooperation, the company representatives visited TÜBİTAK MAM KE laboratories and received information about the relevant studies.
Share this News
For questions and suggestionsContact Us
Most Recent
The SciREACT Project's Closing Conference Was Held
At the closing conference of the SciREACT Project, coordinated by TÜBİTAK MAM, the project’s concrete outcomes and the Pandemic-X Workshop report were presented. The Ministry of Industry and Technology...
TÜBİTAK MAM Hosted the Marmara Region Natural Disasters Workshop
As part of the series of Marmara Region Natural Disaster Workshops organized under the coordination of the Presidency of the Republic of Turkey’s Council on Local Governance and Disaster Policies, “Climate, Water...
The SUPREME Project Kickoff Meeting, Hosted by TÜBİTAK MAM, Was Held
At the kick-off meeting hosted by TÜBİTAK MAM as part of the SUPREME project, international partners from seven countries discussed sustainable and high-performance hydrogen production...
Representatives Gathered for a Technology Roadmap for the Maritime Industry
At the workshops organized as part of the project—which is carried out with the support of UDHAM and coordinated by TÜBİTAK MAM—participants provided assessments regarding the maritime sector’s technology roadmap...